D-chiro-inositol modulates brain insulin-related signaling and reduces amyloid burden, neuroinflammation and cognitive decline in preclinical models of Alzheimer's disease.
- DOI
- 10.1016/j.biopha.2026.119629
- Published
- 2026 Aug
- Container
- Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.biopha.2026.119629,
title = {D-chiro-inositol modulates brain insulin-related signaling and reduces amyloid burden, neuroinflammation and cognitive decline in preclinical models of Alzheimer's disease.},
author = {Pacheco-Sánchez B and López-Gambero AJ and Gavito AL and Rivera P and Suárez J and Sanjuan C and Nilsson P and Tambaro S and de Fonseca FR},
year = {2026},
journal = {Biomedicine \& pharmacotherapy = Biomedecine \& pharmacotherapie},
doi = {10.1016/j.biopha.2026.119629},
url = {https://doi.org/10.1016/j.biopha.2026.119629}
}RIS
TY - JOUR TI - D-chiro-inositol modulates brain insulin-related signaling and reduces amyloid burden, neuroinflammation and cognitive decline in preclinical models of Alzheimer's disease. AU - Pacheco-Sánchez B AU - López-Gambero AJ AU - Gavito AL AU - Rivera P AU - Suárez J AU - Sanjuan C AU - Nilsson P AU - Tambaro S AU - de Fonseca FR PY - 2026 JO - Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie DO - 10.1016/j.biopha.2026.119629 UR - https://doi.org/10.1016/j.biopha.2026.119629 ER -
APA
B, P., AJ, L., AL, G., P, R., J, S., C, S., P, N., S, T., & FR, D. F. (2026). D-chiro-inositol modulates brain insulin-related signaling and reduces amyloid burden, neuroinflammation and cognitive decline in preclinical models of Alzheimer's disease.. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. https://doi.org/10.1016/j.biopha.2026.119629
Source records
- pubmed · retrieved 2026-09-26T13:15:28.041Z